Tag - XAIR

Developments

Beyond Air and TrillaMed deploy LungFit PH into U.S. Natal Hospital Guam NICU

Beyond Air (NASDAQ:XAIR), in partnership with TrillaMed, announced that it will provide its groundbreaking LungFit PH system to the neonatal critical care unit (NICU) at U.S. Naval Hospital Guam, enabling advanced care...

September 27, 2024

Markets

BTIG starts Beyond Air at buy; PT $15

BTIG initiated coverage of Beyond Air (NASDAQ:XAIR) with a “buy” rating and $15 price target. The stock closed at $5.73 on June 14. Beyond Air is a medical device company that has developed a technology to turn room air...

June 15, 2023

Feature

Beyond Air’s cylinder-free nitric oxide delivery system for respiratory conditions

Beyond Air (NASDAQ:XAIR), formerly AIT Therapeutics, is developing a proprietary nitric oxide (NO) generator and delivery system that uses NO generated from ambient air, rather than bulky cylinders, and delivers precise...

August 20, 2019

Tag - XAIR

Beyond Air and TrillaMed deploy LungFit PH into U.S. Natal Hospital Guam NICU

BTIG starts Beyond Air at buy; PT $15

Beyond Air’s cylinder-free nitric oxide delivery system for respiratory conditions

General

More